CH624949A5 - - Google Patents

Download PDF

Info

Publication number
CH624949A5
CH624949A5 CH865776A CH865776A CH624949A5 CH 624949 A5 CH624949 A5 CH 624949A5 CH 865776 A CH865776 A CH 865776A CH 865776 A CH865776 A CH 865776A CH 624949 A5 CH624949 A5 CH 624949A5
Authority
CH
Switzerland
Prior art keywords
methyl
carboxylic acid
dihydro
benzofuran
dichloro
Prior art date
Application number
CH865776A
Other languages
German (de)
English (en)
Inventor
Edward Jethro Jun Cragoe
Otto William Jun Woltersdorf
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Priority to US06/011,651 priority Critical patent/US4254600A/en
Publication of CH624949A5 publication Critical patent/CH624949A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH865776A 1975-07-09 1976-07-06 CH624949A5 (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US06/011,651 US4254600A (en) 1976-01-22 1979-02-12 Mounting for detachably connecting wall panels and the like

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59483975A 1975-07-09 1975-07-09

Publications (1)

Publication Number Publication Date
CH624949A5 true CH624949A5 (ru) 1981-08-31

Family

ID=24380621

Family Applications (1)

Application Number Title Priority Date Filing Date
CH865776A CH624949A5 (ru) 1975-07-09 1976-07-06

Country Status (14)

Country Link
US (2) US4087542A (ru)
JP (1) JPS5210261A (ru)
AU (1) AU505135B2 (ru)
BE (1) BE843644A (ru)
CH (1) CH624949A5 (ru)
DE (1) DE2630800A1 (ru)
DK (1) DK282076A (ru)
ES (1) ES449389A1 (ru)
FR (1) FR2316934A1 (ru)
GB (1) GB1511427A (ru)
HU (1) HU176564B (ru)
NL (1) NL7606908A (ru)
SE (1) SE7607157L (ru)
ZA (1) ZA764080B (ru)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100294A (en) 1976-12-06 1978-07-11 Merck & Co., Inc. 5-(Hydroxy (substituted) methyl)-2,3-dihydrobenzo furan-2-carboxylic acid and its derivatives
US4205080A (en) * 1977-07-21 1980-05-27 Shell Oil Company 2,3-Dihydro benzofuran carboxamides
US4189496A (en) * 1978-02-16 1980-02-19 Merck & Co., Inc. 2,3-Dihydro-5-thienylmethyl and furylmethyl-6-substituted and 6,7-disubstituted-benzofuran-2-carboxylic acid
EP0019955A1 (en) * 1979-05-16 1980-12-10 Shell Internationale Researchmaatschappij B.V. Benzofurancarboxylic acid derivatives, their preparation and their inclusion in lipogenesis inhibiting compositions
US4237130A (en) * 1979-06-21 1980-12-02 Merck & Co., Inc. 2,3-Dihydro-6,7-disubstituted-5-(substituted sulfonyl)benzofuran-2-carboxylic acids
US4237144A (en) * 1979-06-21 1980-12-02 Merck & Co., Inc. 2,3-Dihydro-2,6,7-trisubstituted-5-acylbenzofurans
JPS5737737A (en) * 1980-08-15 1982-03-02 Fuji Photo Film Co Ltd Magnetic recording medium
US4510322A (en) * 1981-07-13 1985-04-09 Merck & Co., Inc. Indacrinone having enhanced uricosuric
NZ200641A (en) * 1981-07-13 1985-12-13 Merck & Co Inc Pharmaceutical compositions containing(+)and(-)enantiomers of indacrinone
US4435422A (en) * 1982-09-15 1984-03-06 Abbott Laboratories 5-Substituted 2,3-dihydrobenzofuran-2-carboxylic acids and their use in diuretic compositions
JPS5973579A (ja) * 1982-10-19 1984-04-25 Kotobuki Seiyaku Kk ベンゾフラン又はベンゾチオフェン誘導体，この化合物を有効成分とする尿酸排泄剤及びその製造方法
EP0117675B1 (en) * 1983-02-19 1986-07-23 Beecham Group Plc Benzofuran and benzothiophene-carboxylic-acid derivatives
US4578509A (en) * 1983-04-01 1986-03-25 Merck & Co., Inc. Process for preparing a manipulated enantiomer mixture by asymmetric chiral phase transfer catalysis
DE3317884A1 (de) * 1983-05-17 1984-11-22 Hoechst Ag, 6230 Frankfurt 5-(4-chlor-3-sulfamoylbenzoyl)-2,3-dihydro-2-benzofurancarbonsaeuren und verfahren zu ihrer herstellung
US4654365A (en) * 1985-09-26 1987-03-31 Merck & Co., Inc. 2,3-dihydro-5-(3-oxo-2-cyclohexen-1-yl)-2-benzofurancarboxylic acids, and their salts useful in the treatment of brain injury
US6858614B2 (en) * 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenolic guanidine sodium channel blockers
US6858615B2 (en) * 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6903105B2 (en) * 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US20050090505A1 (en) * 2003-08-18 2005-04-28 Johnson Michael R. Methods of reducing risk of infection from pathogens
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
EP3428153A1 (en) 2012-12-17 2019-01-16 Parion Sciences, Inc. 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
WO2014099676A1 (en) 2012-12-17 2014-06-26 Parion Sciences, Inc. Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH508615A (de) * 1968-05-30 1971-06-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen heterocyclischen Carbonsäuren
FR2201883B1 (ru) * 1972-10-05 1975-10-31 Roussel Uclaf

Also Published As

Publication number Publication date
NL7606908A (nl) 1977-01-11
BE843644A (fr) 1976-12-30
DE2630800A1 (de) 1977-01-27
GB1511427A (en) 1978-05-17
AU1540476A (en) 1978-01-05
ZA764080B (en) 1978-02-22
JPS5210261A (en) 1977-01-26
HU176564B (en) 1981-03-28
DK282076A (da) 1977-01-10
FR2316934A1 (fr) 1977-02-04
FR2316934B1 (ru) 1979-07-20
US4087542A (en) 1978-05-02
AU505135B2 (en) 1979-11-08
SE7607157L (sv) 1977-01-10
US4163794A (en) 1979-08-07
ES449389A1 (es) 1977-12-16

Similar Documents

Publication Publication Date Title
CH624949A5 (ru)
US4296122A (en) 2,3-Dihydro-6,7-disubstituted-5-(acyl)benzofuran-2-carboxylic acids
DE2754068A1 (de) 5- eckige klammer auf hydroxy-(subst.)- methyl eckige klammer zu -2,3-dihydrobenzofuran-2-carbonsaeuren und ihre derivate
US4154742A (en) Certain 5-substituted or unsubstituted phenyl or furyl benzofuran 2-carboxylic acids
US4401669A (en) 2,3-Dihydro-substituted-5-benzoyl benzofuran-2-carboxylic acids and their use in treating hypertension
DE3411993A1 (de) Substituierte benzopyrane, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimittel
US4181727A (en) 2,3-Dihydro-6,7-disubstituted-5-acyl benzofuran-2-carboxylic acids
DE2941869C2 (ru)
CH617689A5 (ru)
DD238792A5 (de) Verfahren zur herstellung von benzothiophen-derivaten
DE1518973A1 (de) Verfahren zur Herstellung von Dibenzocycloheptatrienverbindungen
DE2314639A1 (de) Pharmakodynamisch aktive aminoalkyloximaether
DE2337068A1 (de) 1-benzylindenylsaeuren
DE2542611A1 (de) Benzofuranderivate
DE2619617C2 (ru)
DE2655195A1 (de) Alkanolaminderivate
DE2731662A1 (de) 5-(2-furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- und 5-(3-thenoyl)-1,2- dihydro-3h-pyrrolo- eckige klammer auf 1,2-a eckige klammer zu -pyrrol-1-carbonsaeurederivate und verfahren zur herstellung derselben
CH636076A5 (de) Benzylalkoholderivate und verfahren zu deren herstellung.
AT345781B (de) Verfahren zur herstellung von neuen 3- aminomethyl-2-phenylbicyclo (2,2,2) octanen und -octenen sowie deren saeureadditionssalzen
DE1927452C3 (de) 2,3-Dihydrobenzofuran-2-carbonsäuren und deren Salze mit pharmakologisch verträglichen anorganischen oder organischen Basen und Verfahren zur deren Herstellung sowie Arzneimittel mit einem Gehalt an diesen Verbindungen
DE3641907A1 (de) 4h-benzo(4,5)cyclohepta(1,2-b)thiophen derivate
DD201678A5 (de) Verfahren zur herstellung von 1,5-bis-(1,4-benzodioxin-2-yl)-3-azapentan-1,5-diolen, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung
EP0003359B1 (de) Spezifische optische Isomeren von 2-Aminoäthyl-1,4-benzodioxanen, Verfahren zu ihrer Herstellung, sowie pharmazeutische Präparate enthaltend diese Verbindungen
AT381938B (de) Verfahren zur herstellung von neuen spirobenzofuranonverbindungen
EP0167945A2 (de) Phenylethylaminopropiophenon-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Legal Events

Date Code Title Description
PL Patent ceased